@misc{indiciae0ea6a8598d44,
  title = {Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors.},
  author = {Lucy Haggstrom and Yeh Chen Lee and Maria-Pilar Barretina-Ginesta and Anna Jaeger and Linn Woelber and Hannah Woopen and Madeline Rhind and Jean-S\&\#xe9;bastien Frenel and Aanum Aanum and Katharina Bischof and Marta Mongillo and Allison L Brodsky and Jonathan Ledermann and Talayeh S Ghezelayagh and Ingrid Boere and Sabrina Kaiser and Constanza Maximiano and Ora Rosengarten and Tamar Safra and Ana Pertejo and Sabrina Cecere and Isabelle Ray-Coquard and Stephanie Lheureux and Ros Glasspool and Marta Gil-Martin and Laura Tookman and Se Ik Kim and Suzana Mittelstadt and Miguel Corbellas Aparicio and Isabel Palacio and Cristina Martin-Lorente and Rebecca Kristeleit and Helena de la Cueva and Nelleke Ottevanger and Maria Quind\&\#xf3;s Varela and Hiroyuki Yoshida and Theresa Link and Lydia Gaba and Gloria Marquina and Nikki Burdett and Paul Johannet and Juliane Reichenbach and Tjoung-Won Park-Simon and Philip H Klecker and Antonio Gonz\&\#xe1;lez-Mart\&\#xed;n and Christian Marth and Clemens Liebrich and Levan Dzotsenidze and Sabine Heublein and Lawrence Kasherman and Cristina Perez and Maria Masvidal and Pau Guill\&\#xe9;n Sent\&\#xed;s and Nikolaus de Gregorio and Franziska Hemptenmacher and Felix Hilpert and Jalid Sehouli and Clare Scott and Katherine Mary Tucker and Jack Dong and Cristina Fortuno and Amanda B Spurdle and Michael Friedlander and Gynecologic Cancer InterGroup Collaboration Into Exceptional Responders to PARP Inhibitors (GCIG-CERP)},
  year = {2026},
  doi = {10.1001/jamaoncol.2026.1924},
  url = {https://pubmed.ncbi.nlm.nih.gov/42348196/},
  note = {Source identifier: 42348196}
}